![]() | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Lilotomab.
|
This is the
talk page for discussing improvements to the
Lilotomab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
![]() | This article is rated Stub-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
|
Offically linked. Remove unlinked please — Preceding unsigned comment added by 2601:2c1:8002:1a30:a018:9591:5ade:e6df ( talk • contribs) 02:16, 4 January 2016 (UTC)
I am not an experienced Wikipedia user, but created the initial versions of both Tetulomab and Betalutin. These articles have been combined into one which I think is not correct. Betalutin is the monoclonal antibody Tetulomab linked to radioactive Lutetium-177. The radioactive Lutetium-177 emits the beta radiation that kills cancer cells. The major group interested will be cancer patients searching for clinical trial information. (The first patient treated with Betalutin is still alive.) Patients will search using both Google and Wikipedia for Betalutin, not Tetulomab.
I suggest an undo of the merging of Tetulomab and Betalutin?
RajeRaje ( talk) 13:49, 10 August 2016 (UTC) RajaRaje
![]() | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Lilotomab.
|
This is the
talk page for discussing improvements to the
Lilotomab article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
![]() | This article is rated Stub-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
|
Offically linked. Remove unlinked please — Preceding unsigned comment added by 2601:2c1:8002:1a30:a018:9591:5ade:e6df ( talk • contribs) 02:16, 4 January 2016 (UTC)
I am not an experienced Wikipedia user, but created the initial versions of both Tetulomab and Betalutin. These articles have been combined into one which I think is not correct. Betalutin is the monoclonal antibody Tetulomab linked to radioactive Lutetium-177. The radioactive Lutetium-177 emits the beta radiation that kills cancer cells. The major group interested will be cancer patients searching for clinical trial information. (The first patient treated with Betalutin is still alive.) Patients will search using both Google and Wikipedia for Betalutin, not Tetulomab.
I suggest an undo of the merging of Tetulomab and Betalutin?
RajeRaje ( talk) 13:49, 10 August 2016 (UTC) RajaRaje